SG10202006016QA - Carboxylic acid for treating/preventing nasal congestion - Google Patents

Carboxylic acid for treating/preventing nasal congestion

Info

Publication number
SG10202006016QA
SG10202006016QA SG10202006016QA SG10202006016QA SG10202006016QA SG 10202006016Q A SG10202006016Q A SG 10202006016QA SG 10202006016Q A SG10202006016Q A SG 10202006016QA SG 10202006016Q A SG10202006016Q A SG 10202006016QA SG 10202006016Q A SG10202006016Q A SG 10202006016QA
Authority
SG
Singapore
Prior art keywords
treating
carboxylic acid
nasal congestion
preventing nasal
preventing
Prior art date
Application number
SG10202006016QA
Other languages
English (en)
Inventor
Bettina Ernst
Original Assignee
Proponent Biotech Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proponent Biotech Gmbh filed Critical Proponent Biotech Gmbh
Publication of SG10202006016QA publication Critical patent/SG10202006016QA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG10202006016QA 2016-05-17 2017-05-17 Carboxylic acid for treating/preventing nasal congestion SG10202006016QA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16169882 2016-05-17

Publications (1)

Publication Number Publication Date
SG10202006016QA true SG10202006016QA (en) 2020-07-29

Family

ID=56014856

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201808322PA SG11201808322PA (en) 2016-05-17 2017-05-17 Carboxylic acid for treating/preventing nasal congestion
SG10202006016QA SG10202006016QA (en) 2016-05-17 2017-05-17 Carboxylic acid for treating/preventing nasal congestion

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201808322PA SG11201808322PA (en) 2016-05-17 2017-05-17 Carboxylic acid for treating/preventing nasal congestion

Country Status (13)

Country Link
US (1) US20200000751A1 (ru)
EP (1) EP3458043A1 (ru)
JP (1) JP6975473B2 (ru)
KR (1) KR102430892B1 (ru)
CN (1) CN109152754A (ru)
AU (1) AU2017266726A1 (ru)
BR (1) BR112018072177A2 (ru)
CA (1) CA3020485A1 (ru)
CL (1) CL2018003270A1 (ru)
MX (1) MX2018013475A (ru)
RU (1) RU2018143564A (ru)
SG (2) SG11201808322PA (ru)
WO (1) WO2017198702A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11206245B2 (en) * 2009-10-14 2021-12-21 Trice Imaging, Inc. Systems and devices for encrypting, converting and interacting with medical images
US11948678B2 (en) * 2009-10-14 2024-04-02 Trice Imaging, Inc. Systems and devices for encrypting, converting and interacting with medical images

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063363A (en) * 1997-05-27 2000-05-16 Goodwin; Gary J Treatment for upper respiratory tract infections with potassium salts
MY121744A (en) * 1997-12-23 2006-02-28 Schering Corp Composition for treating respiratory and skin dieseases, comprising at least one leukotriene antogonist and at least one antihistamine.
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
US20070256812A1 (en) * 2006-04-19 2007-11-08 Wen-Chen Wei Multidirectional heat dissipating structure
US20070286812A1 (en) * 2006-06-09 2007-12-13 Toutounghi Camille Nasal formulation
ES2748632T3 (es) * 2012-10-03 2020-03-17 Proponent Biotech Gmbh Composición farmacéutica que comprende ácido propiónico para uso en el tratamiento de infecciones víricas

Also Published As

Publication number Publication date
RU2018143564A (ru) 2020-06-17
CN109152754A (zh) 2019-01-04
JP6975473B2 (ja) 2021-12-01
KR102430892B1 (ko) 2022-08-09
SG11201808322PA (en) 2018-10-30
JP2019516797A (ja) 2019-06-20
US20200000751A1 (en) 2020-01-02
RU2018143564A3 (ru) 2020-07-23
CL2018003270A1 (es) 2019-02-22
BR112018072177A2 (pt) 2019-02-12
WO2017198702A1 (en) 2017-11-23
KR20190009294A (ko) 2019-01-28
MX2018013475A (es) 2019-08-12
CA3020485A1 (en) 2017-11-23
EP3458043A1 (en) 2019-03-27
AU2017266726A1 (en) 2018-10-11

Similar Documents

Publication Publication Date Title
IL291533A (en) Compounds and preparations including them for the treatment of diseases of the central nervous system
HK1249003A1 (zh) 呼吸輔助器械
GB2598221B (en) Breathing assistance apparatus
IL279308A (en) Methods for the treatment of heptidine-mediated disorders
HK1248152A1 (zh) 鼻用設備
IL250524A0 (en) Carboxylic acid compound, method for its preparation and use
HK1252611A1 (zh) 吸鼻器
HRP20190331T1 (hr) Naprava za nazalno raspršivanje
PT2896395T (pt) Formulação para o tratamento de feridas tópicas
GB201508114D0 (en) Respirator tab
HK1245068A1 (zh) 鼻擴張器
IL253914A0 (en) 1-Heterocyclyl isochromanyl compounds and analogs for the treatment of cns disorders
SG11201706506YA (en) Acetic acid process
DK3200779T3 (en) Novel anthranilic acid derivatives
EP3095479A4 (en) BREATHING ASSISTANCE DEVICE
HK1258273A1 (zh) 用於傷口閉合的裝置
GB201512582D0 (en) Wound treatment
SG10202006016QA (en) Carboxylic acid for treating/preventing nasal congestion
PL3325012T3 (pl) Kompozycja zawierająca cyneol do leczenia polipów nosa
PL3244885T3 (pl) Kwas liponowy do leczenia lub zapobiegania zagrożeniu poronieniem lub przedwczesnym porodem
AP2016009246A0 (en) Device and process for inductively suppressing acid mist from electrowinning
GB201420348D0 (en) Compounds for treating neurodegenerative diseases
PL2975004T3 (pl) Obróbka kwasowych ścieków
GB201516895D0 (en) Wound treatment
GB201513506D0 (en) Wound treatment